Coexisting of COX7A2L-ALK, LINC01210-ALK, ATP13A4-ALK and Acquired SLCO2A1-ALK in a Lung Adenocarcinoma with Rearrangements Loss During the Treatment of Crizotinib and Ceritinib: A Case Report

Cai, CZ; Long, YL; Li, YY; Huang, MJ

Huang, MJ (corresponding author), Sichuan Univ, West China Hosp, Canc Ctr, Dept Thorac Oncol, 37 Guoxue Alley, Chengdu 610041, Sichuan, Peoples R China.

ONCOTARGETS AND THERAPY, 2020; 13 (): 8313

Abstract

ALK rearrangements account for-5% of non-small-cell lung cancer (NSCLC). Numerous rearrangement partners have been discovered. Here, we describe a 53-......

Full Text Link